Roy Nofech‐Mozes
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- Circular RNAs in diseases
- Extracellular vesicles in disease
- Renal and related cancers
Papers in
-
- Renal and related cancers 6
-
- Renal cell carcinoma treatment 6
- Ferroptosis and cancer prognosis 3
- Co-authors
- George M. Yousef (6 shared papers)Henriett Butz (5 shared papers)Heba Khella (4 shared papers)Péter M. Szabó (3 shared papers)Attila Patócs (2 shared papers)Sergey N. Krylov (3 shared papers)Antonio Finelli (2 shared papers)Qiang Ding (1 shared paper)
- Journals
- Oncotarget (2 papers)Journal of Clinical Pathology (1 paper)Clinical Chemistry (1 paper)The FASEB Journal (1 paper)Cancer Medicine (1 paper)
- Partner nations
- CanadaUnited StatesHungary
In The Last Decade
Roy Nofech‐Mozes
8 papers receiving 357 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 223
- Molecular Biology 287
- Pulmonary and Respiratory Medicine 126
- Oncology 35
- Nephrology 9
Countries citing papers authored by Roy Nofech‐Mozes
This map shows the geographic impact of Roy Nofech‐Mozes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Nofech‐Mozes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Nofech‐Mozes more than expected).
Fields of papers citing papers by Roy Nofech‐Mozes
This network shows the impact of papers produced by Roy Nofech‐Mozes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Nofech‐Mozes. The network helps show where Roy Nofech‐Mozes may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Nofech‐Mozes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 112 | |
| 2 | 2015 | 68 | |
| 3 | 2014 | 49 | |
| 4 | 2016 | 39 | |
| 5 | 2017 | 31 | |
| 6 | 2014 | 27 | |
| 7 | 2017 | 27 | |
| 8 | 2018 | 4 |
About Roy Nofech‐Mozes
Roy Nofech‐Mozes is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Pharmacology, having authored 8 papers that have together received 357 indexed citations. Recurring topics across this work include Renal and related cancers (6 papers), Renal cell carcinoma treatment (6 papers), Ferroptosis and cancer prognosis (3 papers), MicroRNA in disease regulation (2 papers), Cancer Genomics and Diagnostics (2 papers), Pancreatic function and diabetes (1 paper), Biochemical Analysis and Sensing Techniques (1 paper) and Cannabis and Cannabinoid Research (1 paper). The work is most often cited by research in Cancer Research (223 citations), Molecular Biology (287 citations), Pulmonary and Respiratory Medicine (126 citations), Oncology (35 citations) and Nephrology (9 citations). Roy Nofech‐Mozes has collaborated with scholars based in Canada, United States and Hungary. Frequent co-authors include George M. Yousef, Henriett Butz, Heba Khella, Péter M. Szabó, Attila Patócs, Sergey N. Krylov, Antonio Finelli, Qiang Ding, Robert Stewart and Jason Lee. Their work appears in journals such as Oncotarget, Journal of Clinical Pathology, Clinical Chemistry, The FASEB Journal and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.